PARP1 and cancer: Given its pivotal role in antioxidant regeneration, it is not surprising that our genome-scale CRISPR/Cas9 screen identifies C12orf5 (TIGAR) as a dropout candidate gene involved in sensitizing cancer cells to PARP inhibitor olaparib.